AZTA
Price
$30.47
Change
-$0.12 (-0.39%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
1.37B
62 days until earnings call
MASS
Price
$6.54
Change
+$0.39 (+6.33%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
217.24M
62 days until earnings call
Interact to see
Advertisement

AZTA vs MASS

Header iconAZTA vs MASS Comparison
Open Charts AZTA vs MASSBanner chart's image
Azenta
Price$30.47
Change-$0.12 (-0.39%)
Volume$11.14K
Capitalization1.37B
908 Devices
Price$6.54
Change+$0.39 (+6.33%)
Volume$48.69K
Capitalization217.24M
AZTA vs MASS Comparison Chart in %
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. MASS commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Hold and MASS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (AZTA: $30.59 vs. MASS: $6.16)
Brand notoriety: AZTA and MASS are both not notable
AZTA represents the Pharmaceuticals: Other, while MASS is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AZTA: 98% vs. MASS: 136%
Market capitalization -- AZTA: $1.37B vs. MASS: $217.24M
AZTA [@Pharmaceuticals: Other] is valued at $1.37B. MASS’s [@Medical/Nursing Services] market capitalization is $217.24M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $155.76B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.06B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.03B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileMASS’s FA Score has 1 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • MASS’s FA Score: 1 green, 4 red.
According to our system of comparison, MASS is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 4 TA indicator(s) are bullish while MASS’s TA Score has 6 bullish TA indicator(s).

  • AZTA’s TA Score: 4 bullish, 3 bearish.
  • MASS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, MASS is a better buy in the short-term than AZTA.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а +3.91% price change this week, while MASS (@Medical/Nursing Services) price change was +9.03% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.23%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +7.18%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.02%. For the same industry, the average monthly price growth was +5.13%, and the average quarterly price growth was +6.37%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 18, 2025.

MASS is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+3.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($1.37B) has a higher market cap than MASS($217M). MASS YTD gains are higher at: 180.000 vs. AZTA (-38.820). AZTA has higher annual earnings (EBITDA): 11.3M vs. MASS (-68.12M). AZTA has more cash in the bank: 319M vs. MASS (119M). MASS has less debt than AZTA: MASS (4.43M) vs AZTA (52.6M). AZTA has higher revenues than MASS: AZTA (669M) vs MASS (65.6M).
AZTAMASSAZTA / MASS
Capitalization1.37B217M632%
EBITDA11.3M-68.12M-17%
Gain YTD-38.820180.000-22%
P/E RatioN/AN/A-
Revenue669M65.6M1,020%
Total Cash319M119M268%
Total Debt52.6M4.43M1,187%
FUNDAMENTALS RATINGS
AZTA: Fundamental Ratings
AZTA
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
50
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AZTAMASS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOBS28.990.40
+1.40%
Solvay Bank (NY)
BURBY14.690.07
+0.48%
Burberry Group Plc
AELIY8.22N/A
N/A
Anadolu Hayat Emeklilik AS
CHHQY29.50N/A
N/A
China Hongqiao Group Limited
AQIA0.10N/A
N/A
Aquiva Group Inc.